Episode

Oral SERDs for Breast Cancer — Year in Review Series on Relevant New Datasets and Advances

Podcast
Breast Cancer Update
Published
Apr 30, 2026
Duration seconds
3438
Processing state
not_requested
Canonical source
https://breast-oncology.captivate.fm/episode/5924-yir2025-oralserdsbreast
Audio
https://dts.podtrac.com/redirect.mp3/episodes.captivate.fm/episode/a21f43c9-7b04-4a56-a983-9f80af1177ed.mp3
JSON
/v1/public/podcasts/breast-cancer-update-757579/episodes/oral-serds-for-breast-cancer-year-in-review-series-on-relevant-new-datasets-and-advances
Markdown
/podcast/breast-cancer-update-757579/oral-serds-for-breast-cancer-year-in-review-series-on-relevant-new-datasets-and-advances.md

Actions

  • POST https://stenobird.com/v1/public/podcasts/breast-cancer-update-757579/episodes/oral-serds-for-breast-cancer-year-in-review-series-on-relevant-new-datasets-and-advances/transcription-requests
    Idempotently request low-priority transcript generation for this episode.
  • GET https://stenobird.com/podcast/breast-cancer-update-757579/oral-serds-for-breast-cancer-year-in-review-series-on-relevant-new-datasets-and-advances.md
    Read the agent-friendly Markdown representation of this episode resource.

Summary

Dr Aditya Bardia from the University of California Los Angeles and Dr Erica Mayer from Dana-Farber Cancer Institute in Boston, Massachusetts, discuss key clinical trial data surrounding the use of oral SERDs in the management of breast cancer. CME information and select publications here .